Cognoa Receives FDA Marketing Authorization for AI-Diven Autism Diagnosis Aid

Cognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif… Read more

Similar